Skip to content
Screener

Tandem Diabetes Care TNDM Shares (Diluted)

Shares (Diluted) at other companies

Insulet logo
InsuletPODD
69.4M-1.8%
Medtronic logo
MedtronicMDT
1.3B-0.1%
Beta Bionics logo
Beta BionicsBBNX
44.5M+2.7%
AdaptHealth logo
AdaptHealthAHCO
135.8M+0.7%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
20.9M-1.1%
Abbott logo
AbbottABT
1.7B-0.4%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.29B+128%
Enterprise value$1.96B+109%
P/S1.2×+0.7×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net loss$(21,168)$(52,400)$(41,561)$(182,956)
Other comprehensive income (loss):
Unrealized gain (loss) on short-term investments$(692)$(98)$(1,719)$325
Unrealized gain (loss) on cash flow hedges716(612)2,418(612)
Foreign currency translation gains1,3354,3801115,979
Comprehensive loss$(19,809)$(48,730)$(40,751)$(177,264)
Net loss per share - basic and diluted$(0.31)$(0.78)$(0.60)$(2.74)
Weighted average shares used to compute basic and diluted net loss per share69,01167,05068,70666,729

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's shares (diluted)?
Tandem Diabetes Care (TNDM) reported shares (diluted) of 69M in Q2 2026.
How has Tandem Diabetes Care's shares (diluted) changed year-over-year?
Tandem Diabetes Care's shares (diluted) increased by 2.9% year-over-year, from 67.1M to 69M.
What is the long-term trend for Tandem Diabetes Care's shares (diluted)?
Over 4 years (2021 to 2025), Tandem Diabetes Care's shares (diluted) has grown at a 1.0% compound annual growth rate (CAGR), from 258.8M to 269.1M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Tandem Diabetes Care's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude